Sex-specific environmental influences affecting MS development

Clinical Immunology

Volumn 149, Issue 2, 2013, Pages 176-181

  Correale, Jorge ^a   Balbuena Aguirre, María E ^b   Farez, Mauricio F ^a  

^a FLENI   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Environmental factors; Epstein Barr virus; Gender; Multiple Sclerosis; Smoking; Vitamin D

Indexed keywords

COLECALCIFEROL; EPSTEIN BARR VIRUS ANTIGEN; ESTRADIOL; IMMUNOGLOBULIN G; SEX HORMONE;

ARTICLE; CALCIUM HOMEOSTASIS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; EXPANDED DISABILITY STATUS SCALE; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MATERNAL SMOKING; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SUN EXPOSURE;

ENVIRONMENTAL FACTORS; EPSTEIN-BARR VIRUS; GENDER; MULTIPLE SCLEROSIS; SMOKING; VITAMIN D;

ANIMALS; CHOLECALCIFEROL; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; ESTRADIOL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MULTIPLE SCLEROSIS; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84885956502     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.02.006     Document Type: Article

References (61)

1. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
2. Oksenberg J.R., Baranzini S.E., Sawcer S., Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 2008, 9:516-526.
3. Gourraud P.A., Harbo H.F., Hauser S.L., Baranzini S.E. The genetics of multiple sclerosis: an up-to-date review. Immunol. Rev. 2012, 248:122-139.
4. Ebers G.C., Bulman D.E., Sadovnik A.D., Paty D.W., Warren S., Hader W., Murray T.J., Seland T.P., Duquette P., Grey T. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 1986, 315:1638-1642.
5. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann. Neurol. 2007, 61:504-513.
6. Riise T., Groonning M., Klauber M.R., Barret-Connor E., Nyland H., Albreksten G. Clustering of residence of multiple sclerosis patients at age 13 to 20 in Hordaland, Norway. Am. J. Epidemiol. 1991, 133:932-939.
7. Pugliatti M., Riise T., Sotgiu M.A., Satta W.M., Sotgiu S., Pirastru M.I., Rosati G. Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in Sardinian population. Am. J. Epidemiol. 2006, 164:326-333.
8. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnik A.D., Ebers G.C. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006, 5:932-936. for the Canadian collaborative study Group.
9. Sellener J., Kraus J., Awad A., Milo R., Hemmer B., Stüve O. The increasing incidence and prevalence of female multiple sclerosis - a critical analysis of potential environmental factors. Autoimmun. Rev. 2011, 10:495-502.
10. Pugliatti M., Harbo H.F., Holmoy T., Kampman M.T., Myhr K.M., Riise T., Wolfson C. Environmental risk factors in multiple sclerosis. Acta Neurol. Scand. 2008, 117(Suppl. 118):34-40.
11. Orton S.M., Ramagopalan S.V., Brockledabank D., Herrera B.M., Dyment D.A., Yee I.M., Sadovnik A.D., Ebers G.C. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J. Neurol. Neurosurg. Psychiatry 2010, 81:31-36.
12. Kragt J., van Amerongen B., Killestein J., Dijstra C., Uitdehaag B., Polman C., Lips P. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult. Scler. 2009, 15:9-15.
13. Osoegawa M., Kira J., Fukazawa T., Fujihara K., Kikuchi K., Matsui M., Kohriyama T., Sobue G., Yamamura T., Itoyama Y., Saida T., Sakata K., Ochi H., Matsuoka T., Research Committee of Neuroimmunological Diseases Temporal changes and geographical differences in Multiple Sclerosis phenotypes in Japanese: nationwide survey results over 30years. Mult. Scler. 2009, 15:159-173.
14. Ghazeeri G., Abdullah L., Abbas O. Immunological differences in women compared with men: overview and contributing factors. Am. J. Reprod. Immunol. 2011, 66:163-169.
15. Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Hum. Reprod. Update 2005, 11:411-423.
16. Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 2011, 109:87-124.
17. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J. Autoimmun. 2007, 28:1-6.
18. Confavreaux C., Vukusic S., Adelaine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003, 126:770-782.
19. Koch M., Kingwell E., Rieckmann P., Tremlett H., UBC MS Clinic Neurologists The natural history of secondary progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2010, 81:1039-1043.
20. Antulov R., Weinstock-Guttman B., Cox J.L., Hussein S., Durfee J., Caiola C., Dwyer M.G., Bergsland N., Abdelrahman N., Stosic M., Hojnacki D., Munschauer F.E., Miletic D., Zivadinov R. Gender-related differences in MS. A study of conventional and nonconventional MRI measures. Mult. Scler. 2009, 15:345-354.
21. Voskhul R.R., Gold S.M. Sex-related factors in multiple sclerosis susceptibility and progression. Nat. Rev. Neurol. 2012, 8:255-263.
22. Yokomaku D., Numakawa T., Numakawa Y., Suzuki S., Matsumoto T., Adachi N., Nishio C., Taguchi T., Hatanaka H. Estrogen enhances depolarization-induced glutamate release through activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase in cultured hippocampal neurons. Mol. Endocrinol. 2003, 17:831-844.
23. Numakawa Y., Matsumoto T., Yokimaku D., Taguchi T., Niki E., Hatanaka H., Kunugi H., Tumakawa T. 17 beta-estradiol protects cortical neurons against oxidative stress-induced cell death through reduction in the activity of mitogen-activated protein kinase and in the accumulation of intracellular calcium. Endocrinology 2007, 148:627-637.
24. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 1996, 212:13-16.
25. van der Mei I.A., Ponsonby A.I., Dwyer T., Blizzard L., Simmons B., Taylor V., Butzkueven H., Kilpatrick T. Past exposure to sun, skin phenotype and risk of multiple sclerosis case-control study. BMJ 2003, 327:316.
26. Munger K.L., Zhang S.M., O'Reilly E., Hernán M.A., Olek M.J., Willett W.C., Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
27. Hayes C.E., Cantorna M.T., DeLuca H.F. Vitamin D and multiple sclerosis. Proc. Soc. Exp. Biol. Med. 1997, 216:21-27.
28. Tremlett H.I.A., van der Mei F., Pittas F., Blizzard L., Paley G., Mesaros D., Woodhaker R., Nunez M., Dwyer T., Taylor V., Ponsonby L. Monthly ambient sunlight, infections and relapse rate in multiple sclerosis. Neuroepidemiology 2008, 31:271-279.
29. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
30. van der Mei I.A.F., Ponsoby A.L., Dwyer T., Blizzard L., Taylor B.V., Kilpatrick T., Butzkueven H., McMichael A.J. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania. Aust. J. Neurol. 2007, 254:581-590.
31. Autralian, New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) Genome wide association study identifies new multiple sclerosis susceptibility loci in chromosome 12 and 20. Nat. Genet. 2009, 41:824-828.
32. Lemire J.M., Archer D.C. 1,25 dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 1991, 87:1103-1107.
33. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25 dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. 1996, 93:7861-7864.
34. Spach K.M., Hayes C.E. Vitamin D confers protection from autoimmune encephalomyelitis only in female mice. J. Immunol. 2005, 175:4119-4126.
35. Nashold F.E., Spach K.M., Spanier J.A., Hayes C.E. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J. Immunol. 2009, 183:3672-3681.
36. Yague J.G., Garcia-Segura L.M., Azcoitia I. Selective transcriptional regulation of aromatasa gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine 2009, 35:252-261.
37. Byrne I.M., Flanagan L., Tenniswood M.P.R., Welsh J. Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 2000, 141:2829-2836.
38. Correale J., Ysrraelit M.C., Gaitan M.I. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J. Immunol. 2010, 185:4948-4958.
39. Gray T.K., McAdon T., Hatley L., Lester G.E., Thierry M. Fluctuations of serum concentrations of 1,25 dihydroxyvitamin D3 during the menstrual cycle. Am. J. Obstet. Gynecol. 1982, 144:880-884.
40. Aarskog D., Aksnes L., Markestad T., Rodland O. Effects of estrogen on vitamin D metabolism in tall girls. J. Clin. Endocrinol. Metab. 1983, 57:1155-1158.
41. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
42. Bove R.M., Healy B., Augustine A., Musallam A., Gholipour T., Chitnis T. Effect of gender on late onset of multiple sclerosis. Mult. Scler. J. 2012, 18:1472-1479.
43. Handel A.E., Willimason A.I., DIsanto G., Dobson R., Giovannoni G., Ramagopalan S.V. Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 2011, 6:e16149.
44. Sundstrom P., Nystrom L. Smoking worsens the prognosis in multiple sclerosis. Mult. Scler. 2008, 14:1031-1035.
45. Smith A.D.M., Duckett S S., Waters A.H. Neuropathological changes in chronic cyanide intoxication. Nature 1963, 200:179-181.
46. Sopori M.L., Kozak W. Immunomodulatory effects of cigarette smoke. J. Neuroimmunol. 1998, 83:148-156.
47. Costembader K.H., Karlson E.W. Cigarette smoking and autoimmune disease: what can we learn from epidemiology. Lupus 2006, 15:737-745.
48. Mikaeloff Y., Caridade G., Tardieu M., Suissa S. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007, 130:2589-2595.
49. Montgomery S.M., Bahmanyar S., Hillert J., Ekbom A., Olsson T. Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur. J. Neurol. 2008, 15:1395-1399.
50. Palacios N., Alonso A., Bronnum-Hansen H., Ascherio A. Smoking and increased risk of multiple sclerosis: parallel trends in sex ratio reinforce the evidence. Ann. Epidemiol. 2011, 21:536-542.
51. Handel A.E., Williamson A.J., Disanto G., Handunnetthi L., Giovannoni G., Ramogapalan S.V. An update meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010, 5:e12496.
52. Munger K.L., Levin L.I., O'Reilly E.J., Flak K.I., Ascherio A. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult. Scler. J. 2011, 17:1185-1193.
53. Ascherio A., Munger K.L., Lennette E.T., Spiegelman D., Hernán M.A., Olek M.J., Hankinson S.E., Hunter D.J. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001, 286:3083-3086.
54. Levin L.I., Munger K.L., O'Reilly E.J., Falk K.I., Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 2010, 67:824-830.
55. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007, 204:2899-2912.
56. Ascherio A., Bar-Or A. EBV and brain matter(s)?. Neurology 2010, 74:1092-1095.
57. Lang Hl., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., Hjorth P., Sondergaard L., Svejgaard A., Wucherpfennig K., Stuart D.I., Bell J.I., Jones E.Y., Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 2002, 3:940-943.
58. Holmoy T., Vardal F. Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells. J. Neurovirol. 2004, 10:52-56.
59. Ascherio A., Munger K.L. Epstein-Barr virus infection and multiple sclerosis: a review. J. Neuroimmune Pharmacol. 2010, 5:271-277.
60. Nielsen T.R., Pedersen M., Rostgaard K., Frisch M., Hjalgrim H. Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals. Mult. Scler. 2007, 13:420-423. (8).
61. DeJager P.L., Simon K.C., Munger K.L., Rioux J.D., Hafler D.A., Ascherio A. Integrating risk factors: HLA-DRB1+1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008, 70:1113-1118.